Main Session
Sep
28
SS 21 - Immuno-Radiotherapy and Liquid Biomarkers in Gynecologic Cancer: Toward Precision Care
210 - Atezolizumab and Stereotactic Body Radiation in Metastatic, Recurrent, or Persistent Cervical Cancer: Long Term Results and Biomarker Analysis from a Phase II Multi-Institutional Study
Presenter(s)
Kamran Ahmed, MD - H. Lee Moffitt Cancer Center, Tampa, FL